ENO2 and neoplasm: Most recently, Jiang et al. (2018) showed a tumor biomarker, thymidine kinase 1 (TK1) combined with CEA, CYFRA21, and neuron specific enolase (NSE) improves the diagnosis of the squamous cell carcinoma and adenocarcinoma subtypes.